Masaru Matsuda - 04 Sep 2021 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
07 Sep 2021, 17:42:24 UTC
Next SEC filing
05 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James R. Oehler as attorney-in-fact for Masaru Matsuda

Key filing fact

Masaru Matsuda filed Form 4 for HALOZYME THERAPEUTICS, INC. (HALO) on 07 Sep 2021.

Key facts

  • This page summarizes Masaru Matsuda's Form 4 filing for HALOZYME THERAPEUTICS, INC. (HALO).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 07 Sep 2021, 17:42.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$144,055.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HALO transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+6,883
Change %
+42%
Price
$0.000000
Shares after
23,461
Date
04 Sep 2021
Ownership
Direct
HALO transaction

Common Stock

Tax liability

Transaction value
$144,055
Shares
-3,412
Change %
-15%
Price
$42.22
Shares after
20,049
Date
04 Sep 2021
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HALO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-6,883
Change %
-50%
Price
$0.000000
Shares after
6,883
Date
04 Sep 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,883
Exercise price
$0.000000
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported disposition of 3,412 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.

Footnote F2

This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .